Medical Imaging News
Another Drug Moves Amyloid Without Clinical Eff...
In what is becoming a trend among anti-amyloid therapies for Alzheimer's disease, bapineuzumab appeared to clear amyloid plaques from the brains of Alzheimer's patients even though it provided no clinical...
Another Drug Moves Amyloid Without Clinical Eff...
In what is becoming a trend among anti-amyloid therapies for Alzheimer's disease, bapineuzumab appeared to clear amyloid plaques from the brains of Alzheimer's patients even though it provided no clinical...
New Mayo scoring system predicts CCU patient mo...
A predictive scoring system that combines both echocardiography and clinical data can reliably estimate three-year death rates in critical care unit (CCU) patients, according to research from the Mayo Clinic...
New Mayo scoring system predicts CCU patient mo...
A predictive scoring system that combines both echocardiography and clinical data can reliably estimate three-year death rates in critical care unit (CCU) patients, according to research from the Mayo Clinic...
Gadolinium Brain Deposits on FDA Radar
The US Food and Drug Administration (FDA) is looking into the risk for brain deposits with repeated use of gadolinium-based contrast agents (GBCAs) for MRI, the agency said today in...
Gadolinium Brain Deposits on FDA Radar
The US Food and Drug Administration (FDA) is looking into the risk for brain deposits with repeated use of gadolinium-based contrast agents (GBCAs) for MRI, the agency said today in...
Insulin Resistance May Impair Glucose Metabolis...
Insulin resistance was associated with lower regional cerebral glucose metabolism in an imaging study of participants at risk for Alzheimer's disease (AD). All of the participants underwent a series of...
Insulin Resistance May Impair Glucose Metabolis...
Insulin resistance was associated with lower regional cerebral glucose metabolism in an imaging study of participants at risk for Alzheimer's disease (AD). All of the participants underwent a series of...
Amyloid Imaging May Shift Alzheimer's Management
Using florbetapir (Amyvid) imaging to see amyloid plaques in the brain altered treatment course, but it's not clear whether that translates to clinical benefit, researchers reported here. {read more here}
Amyloid Imaging May Shift Alzheimer's Management
Using florbetapir (Amyvid) imaging to see amyloid plaques in the brain altered treatment course, but it's not clear whether that translates to clinical benefit, researchers reported here. {read more here}
Gantenerumab: Was Dosing the Problem?
Leaders of failed Alzheimer's drug trial suggest a higher dose would work. Further analyses of data from the halted SCarlet RoAD study of the anti-amyloid drug gantenerumab for Alzheimer's disease...
Gantenerumab: Was Dosing the Problem?
Leaders of failed Alzheimer's drug trial suggest a higher dose would work. Further analyses of data from the halted SCarlet RoAD study of the anti-amyloid drug gantenerumab for Alzheimer's disease...